MetaCap

Solid Biosciences (SLDB) News

NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.25-0.19 (-2.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SLDB news summary

We found 4 recent headlines mentioning Solid Biosciences (SLDB): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, SLDB is down 2.95% at $6.25. The most recent story, "Solid Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference", was published by GlobeNewswire on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Solid Biosciences headlines

Compare SLDB